Olema Oncology at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Olema Oncology at SABCS 2026 in San Antonio: Booth 1342.
| Organization | SABCS 2026 Attendance |
|---|---|
Olema Oncology San Francisco, CA | |
Clinical-stage company developing palazestrant, an oral estrogen receptor antagonist and degrader, in Phase 3 trials for ER+/HER2- advanced breast cancer. | Booth Exhibiting at Booth 1342 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers from Olema Oncology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction